Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dania Kaehlyn Helgeson
Observed name:
Dania K. Helgeson
Observed institution:
Mayo Clinic
OpenAlex ID:
A5063276388
Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
2022
·
Eli Muchtar
, Morie A. Gertz
, et al.
·
Blood Advances
·
10
PDF
Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone for Treatment of Previously Untreated Light Chain Amyloidosis
2020
·
Eli Muchtar
, Morie A Gertz
, et al.
·
Blood
·
5
Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients with Multiple Myeloma with Extramedullary Disease or Plasma Cell Leukemia
2020
·
Francis K. Buadi
, Martha Q. Lacy
, et al.
·
Blood
·
2
Phase 2 Trial of LDE225 and Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma
2019
·
Francis K. Buadi
, Martha Q. Lacy
, et al.
·
Blood
·
2
Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone in Relapsed Multiple Myeloma
2019
·
Francis K. Buadi
, Martha Q. Lacy
, et al.
·
Blood
Show more works
View as search
Works count:
5
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type
